ah's on the 11th of September (4:04PM)
News News Alert: Annual Report (10-k) 09/11/2018 04:04:21 PM
as a reminder ..
Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.452Up 0.017 (3.91 %)AS OF 3:59:27PM ET 09/11/2018
Last Trade 0.452
Trade Time 3:59:27pm ET
Change 0.017
% Change 3.91%
Bid 0.445
Bid Size 2500
Ask 0.455
Ask Size 2500
Open 0.425
Day High 0.47 ** .045c *liquidity*
Day Low 0.425
Previous Close
09/10/2018 0.435
52-Week High
12/06/2017 1.17
52-Week Low
06/21/2018 0.325
Price Performance (Last 52 Weeks)
09/10/2018 -42.78%
Volume 86,434
Volume (10 day Average) 157,875
Volume (90 day Average) 193,560
last grab B/A .. 9.11.18 .. may not align with Fido's above ..
NITE 0.445 2,500 15:18
ETRF 0.44 3,000 14:56
CDEL 0.41 2,850 15:06
VERT 0.38 2,500 09/10
CANT 0.38 2,500 13:02
LAFC 0.3625 2,500 09/07
CSTI 0.36 2,500 08:30
STXG 0.30 2,500 04/17
VNDM 0.30 2,500 09/10
PUMA 0.30 2,500 08:10
MAXM 0.0001 10,000 09/10
DBOX U 0 04/16
OTCX U 0 09:30
NITE 0.455 2,500 14:47
CANT 0.46 2,500 13:02
ETRF 0.47 3,000 14:09
VERT 0.50 2,500 12:01
OTCX 0.52 8,000 15:18
CSTI 0.53 1,000 08:30
LAFC 0.60 1,000 09:30
VNDM 0.64 1,000 09/10
CDEL 0.68 12,000 15:06
PUMA 0.70 1,000 08:10
STXG 2.00 100 10/05
MAXM 8.00 100 09/10
DBOX U 0 04/16
reminder too .. as of EO August 2018 .. IPIX's *volume* was running 10M~ less than EO August's 2017 (YTD) *volume*
https://investorshangout.com/post/view?id=5208838
mgmt's filings and PRs/Updates issued since 9.11.18
October 24, 2018
INNOVATION PHARMACEUTICALS GRANTED END-OF-PHASE 2 MEETING
October 22, 2018
INNOVATION PHARMACEUTICALS PROVIDES UPDATE ON KEVETRIN PROGRAM; BRIDGING TOXICOLOGY EFFORTS AIMED AT DEVELOPING AN ORAL P53 ANTI-CANCER DRUG CANDIDATE
October 12, 2018
INNOVATION PHARMACEUTICALS BRILACIDIN AS A NOVEL INHIBITOR OF PHOSPHODIESTERASE 4 (PDE4) SUPPORTS ITS POTENTIAL TO TREAT AUTOIMMUNE AND INFLAMMATORY DISEASES
October 9, 2018
INNOVATION PHARMACEUTICALS SECURES UP TO $10 MILLION IN ADDITIONAL FINANCING TO ADVANCE CLINICAL PIPELINE
September 24, 2018
INNOVATION PHARMACEUTICALS PROVIDES A COMPARATIVE PERSPECTIVE ON BRILACIDIN’S POTENTIAL TO UNLOCK THE ORAL MUCOSITIS MARKET: PHARMA INDUSTRY ATTACKS SEVERE PAIN AND SUFFERING DUE TO CANCER TREATMENTS
September 20, 2018
INNOVATION PHARMACEUTICALS PROVIDES CORPORATE UPDATE HIGHLIGHTING UPCOMING MILESTONES AND EVENTS
Form Type Description Filing Date Files
8-K Current report, item 7.01 2018-10-24
4 Statement of changes in beneficial ownership ... 2018-10-16
4 Statement of changes in beneficial ownership ... 2018-10-15
8-K Current report, item 7.01 2018-10-10
8-K Current report, items 1.01, 5.03, 7.01, and 9... 2018-10-09
424B5 Prospectus 2018-10-09
4 Statement of changes in beneficial ownership ... 2018-09-24
4 Statement of changes in beneficial ownership ... 2018-09-24
8-K Current report, item 5.02 2018-09-21
http://www.ipharminc.com/press-release/
=======================================
and today .. 6 weeks and 3 days on from 9.11.18
Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.136Down -0.0014 (-1.02 %)AS OF 3:55:39PM ET 10/26/2018
Last Trade 0.136
Trade Time 3:55:39pm ET
Change -0.0014
% Change -1.02%
Bid 0.133
Bid Size 5000
Ask 0.1375
Ask Size 10000
Open 0.138
Day High 0.14 ** .017c *liquidity*
Day Low 0.123
Previous Close
10/25/2018 0.1374
52-Week High
12/06/2017 1.17
52-Week Low
10/19/2018 0.12
Price Performance (Last 52 Weeks)
10/25/2018 -80.37%
Volume 876,765
Volume (10 day Average) 854,566
Volume (90 day Average) 394,730
last grab B/A ..
VERT 0.133 5,000 15:50
NITE 0.1305 5,000 15:50
ETRF 0.125 10,000 15:40
CDEL 0.122 5,000 14:40
CANT 0.121 5,000 08:30
VERT 0.1375 5,000 14:34
CSTI 0.1375 5,000 15:49
NITE 0.19 12,861 15:55
CDEL 0.23 31,250 14:40
VNDM 0.23 2,500 10/25
a good weekend to all Innovation Pharma investors ..
4kids
(4)
(0)
